Feature | December 15, 2014

St. Joseph's Children's Hospital Implants 50th Pulmonary Valve Without Open-Heart Surgery

Facility is highest-volume Melody valve implanting center in Florida, one of the busiest in the United States


December 15, 2014 — Doctors at St. Joseph’s Children’s Hospital of Tampa implanted a Melody transcatheter pulmonary valve in a 13-year-old patient in October, marking the 50th time the hospital has given the device to a patient.

Thirteen-year-old Cyrus Yarley was born with multiple heart defects and underwent open-heart surgery at just 1 week old then again at age 8. His mother, Valorie Daniels, knew the day would come when Cyrus would need to have his pulmonary valve replaced, and had anticipated another open-heart surgery for the past five years. Use of the Melody valve, however, precluded the need for an additional incision. After inserting a catheter into a vein in the upper leg, pediatric cardiologist Jeremy Ringewald, M.D., guided the Melody valve up to Cyrus' heart and replaced his current dysfunctional pulmonary valve

The Melody valve from Medtronic replaces narrow or leaky pulmonary valve conduits in children or adults who have previously undergone congenital heart surgery. St. Joseph's Children's Hospital is the highest-volume Melody valve implanting center in Florida and one of the busiest in the United States.

"Children born with blocked or leaky heart valves usually undergo multiple open-heart surgeries before reaching adulthood to replace conduits that have worn out or that they have outgrown," said Ringewald. "This groundbreaking technology can markedly prolong the time between surgeries for many patients, with the goal of maximizing heart health and minimizing invasiveness."

According to Ringewald, the Melody valve procedure is typically performed under general anesthesia in less than four hours. Unlike open-heart surgical procedures, where the hospital stay is approximately a week, patients are usually discharged from the hospital within 24 hours. 

While Melody valve therapy cannot be used in all cases of abnormal pulmonary valve function, it can give doctors an alternative to repeated traditional open-heart procedures, offering children and adults who may not be able to tolerate another open-heart surgery hope for the future.

For more information: www.medtronic.com


Related Content

News | Heart Valve Technology

March 30, 2025 — Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data ...

Home March 31, 2025
Home
News | Heart Valve Technology

Feb. 22, 2025 — More than 60,000 people die from heart valve disease (HVD) in the U.S. each year, according to the ...

Home March 04, 2025
Home
News | Heart Valve Technology

Feb. 17, 2025 — The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally inclusive ...

Home February 18, 2025
Home
News | Heart Valve Technology

Feb. 13, 2025 — Research from Cedars-Sinai investigators and collaborators at other leading medical institutions is ...

Home February 18, 2025
Home
News | Heart Valve Technology

Jan. 25, 2025—A new study presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that ...

Home January 27, 2025
Home
News | Heart Valve Technology

Jan. 6, 2025 — Medtronic plc has announced it received CE (Conformité Européenne) Mark for the Harmony Transcatheter ...

Home January 06, 2025
Home
News | Heart Valve Technology

Sept. 1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid ...

Home September 04, 2024
Home
News | Heart Valve Technology

June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...

Home June 27, 2024
Home
News | Heart Valve Technology

June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed ...

Home June 21, 2024
Home
News | Heart Valve Technology

June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial ...

Home June 10, 2024
Home
Subscribe Now